Anjac Health & Beauty Group to which LABORATOIRES CHEMINEAU belongs is strengthening its presence in North America with the acquisition of Pillar5 Pharma Inc. !

Key stakeholder in the North American market, Pillar5 Pharma Inc. is a CDMO specialized in the development and production of sterile and preservative-free ophthalmic solutions.

After Apollo Health and Beauty Care 1 month ago, Pillar5 Pharma Inc. is the 14th company to join the ANJAC group.

« We’re very pleased with this strategic acquisition. It will foster our growth in a new key sector, the ophthalmology market, specifically through sterile, multidose preservative free ophthalmic solutions, an innovation with high added value », says Aurélien Chaufour, President of ANJAC.

Press release : https://lnkd.in/eyYZFjUH